KenSci foretells $22m series B

KenSci, a US-based predictive healthcare analysis software developer co-founded by a University of Washington professor, closed a $22m series B round on Thursday backed by university-focused VC fund Osage University Partners (OUP).
Healthcare-focused investment firm Polaris Partners led the round, which also featured safety and regulatory services provider UL’s investment subsidiary, UL Ventures, along with venture firms Ignition Partners and Mindset Ventures.
Founded in 2015, KenSci develops machine learning and predictive analytics-powered software apps for the healthcare sector than help clients anticipate illnesses in high-risk group of patients and plan appropriate responses.
KenSci’s products draw upon data extracted from electronic medical records, insurance claims, billings, pharmacy stores, wearable devices and psychosocial databases.
The series B capital will go towards activities that support KenSci’s product roadmap and global expansion plans, and the company expects to benefit from UL’s global presence and expertise in the compliance industry.
KenSci’s founding team includes Ankur Teredesai, a professor of computer science and systems in the Institute of Technology at Washington’s Tacoma campus.
The company has now raised $30.5m of funding altogether, following an $8.5m series A round in January 2017 led by Ignition Partners with contributions from OUP and Mindset Ventures.